Edwards Lifesciences layoffs, on the record
Every job cut, severance charge and restructuring Edwards Lifesciences reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 19,800 to approximately 16,000.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 19,800 | December 31, 2023 |
| 10-K for 2024 | approximately 15,800 | December 31, 2024 |
| 10-K for 2025 | approximately 16,000 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryRecorded severance-driven expense for a global workforce realignment, affecting about 360 employees.
Word for word“In September 2024, we recorded an expense of $32.9 million primarily related to severance expenses associated with a global workforce realignment impacting approximately 360 employees.” 10-K for 2024
Our summaryThe company recorded severance expenses tied to realignment initiatives in 2025 and 2024.
Word for word“In 2025 and 2024, we recorded expenses of $13.1 million and $32.9 million, respectively, related to severance associated with realignment initiatives.” 10-K for 2025
| Fiscal year ended | Restructuring charges | Cash paid for restructuring |
|---|---|---|
| 2024-12-31 | $32.9 million | $12.8 million |
| 2025-12-31 | $13.1 million | $19.9 million |
Edwards Lifesciences has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Edwards Lifesciences’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.